MOMA houses a close synergy between research, development and clinical activities. The department has a unique position in the form of an interface between Aarhus University (AU), Aarhus University Hospital (AUH) and the National Genome Center (NGC).
MOMA holds a laboratory and core centers with specialised staff and equipment ready to solve internal and external tasks. We function as a diagnostic NGS core facility which i.a. includes analysis of hereditary and somatic cancer, hereditary heart disease and hereditary endocrine disorders.
MOMA serves as the National Center for Whole Genome Sequencing West under the Danish National Genome Center to complete sequencing of 60.000 genomes to contribute in the development of precision medicine to enable better patient diagnosis and treatment.
The department has for several years been at the forefront internationally with research within bladder, colorectal and prostate cancer, as well as the development of bioinformatics, which supports data processing both for research and diagnostic purposes. In addition, MOMA conducts research in targeted cancer treatment, kidney cancer and hereditary endocrine disease.
MOMA functions as an interdisciplinary hub with a wide range of expertise and specialties. The department holds large biobanks with samples collected over decades from patients with various clinical diagnose. These biobanks continue to form a unique basis for research of high clinical relevance and international attention.